KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Operating Leases (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Leases for 7 consecutive years, with $12.9 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 2.02% to $12.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.9 million through Dec 2025, up 2.02% year-over-year, with the annual reading at $12.9 million for FY2025, 2.02% up from the prior year.
  • Operating Leases for Q4 2025 was $12.9 million at Biolife Solutions, down from $13.2 million in the prior quarter.
  • The five-year high for Operating Leases was $17.7 million in Q3 2021, with the low at $8.7 million in Q4 2023.
  • Average Operating Leases over 5 years is $14.2 million, with a median of $15.0 million recorded in 2022.
  • The sharpest move saw Operating Leases surged 67957.69% in 2021, then crashed 41.89% in 2023.
  • Over 5 years, Operating Leases stood at $16.5 million in 2021, then dropped by 9.13% to $15.0 million in 2022, then plummeted by 41.89% to $8.7 million in 2023, then surged by 45.43% to $12.6 million in 2024, then grew by 2.02% to $12.9 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $12.9 million, $13.2 million, and $11.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.